4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001384243-26-000004
Director sold 2,800 shares at $45.00 ($126,000)
- Director acquired 2,800 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Quart Barry D · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-10 | Exercise or conversion : show line 1 in the form 10b5-1 | +110 | $15.47 | $1,702 | 12,656 | D |
| 2026-02-10 | Sale : show line 2 in the form 10b5-1 | −110 | $45.00 | $4,950 | 12,546 | D |
| 2026-02-12 | Exercise or conversion : show line 3 in the form 10b5-1 | +2,690 | $15.47 | $41,614 | 15,236 | D |
| 2026-02-12 | Sale : show line 4 in the form 10b5-1 | −2,690 | $45.00 | $121,050 | 12,546 | D |
| Open-market sales · 2,800 sh · avg $45.00 · $126,000 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-10 | Exercise or conversion : show line 5 in the form 10b5-1 Share Option | −110 | 2,690 | D |
| 2026-02-12 | Exercise or conversion : show line 6 in the form 10b5-1 Share Option | −2,690 | 0 | D |
Loading xslF345X05/form4-02122026_090237.xml…